The following letters (the letters of rejection and the amendments to the application in response to rejections) refer to MAPS' application to the FDA office of Orphan Product Development, "Request for Orphan Drug Designation for Smoked Marijuana in the Treatment of HIV-Associated Wasting Syndrome (application #97-1053).
|